首页 | 本学科首页   官方微博 | 高级检索  
检索        


The epigenetic regulators Bmi1 and Ring1B are differentially regulated in pancreatitis and pancreatic ductal adenocarcinoma
Authors:Carles Martínez‐Romero  Ilse Rooman  Anouchka Skoudy  Carmen Guerra  Xavier Molero  Ana Gonzlez  Mar Iglesias  Tania Lobato  Almudena Bosch  Mariano Barbacid  Francisco X Real  Inmaculada Hernndez‐Muoz
Institution:1. Programa de Recerca en Càncer, Institut Municipal d'Investigació Mèdica (IMIM‐Hospital del Mar), Parc de Recerca Biomèdica de Barcelona, Doctor Aiguader, 88 08003‐Barcelona, Spain;2. Programa de Oncología Molecular, Centro Nacional de Investigaciones Oncológicas, Melchor Fernández Almagro 3, 28029‐Madrid, Spain;3. Grup de Recerca en Fisiologia y Fisiopatologia Digestiva,. Institut de Recerca Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain;4. Departament de Patología, Hospital Universitari del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain;5. Programa de Patología Molecular, Centro Nacional de Investigaciones Oncológicas, Melchor Fernández Almagro 3, 28029‐Madrid, Spain;6. Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain
Abstract:Chronic pancreatitis and pancreatic ductal adenocarcinoma (PDAC) are associated with major changes in cell differentiation. These changes may be at the basis of the increased risk for PDAC among patients with chronic pancreatitis. Polycomb proteins are epigenetic silencers expressed in adult stem cells; up‐regulation of Polycomb proteins has been reported to occur in a variety of solid tumours such as colon and breast cancer. We hypothesized that Polycomb might play a role in preneoplastic states in the pancreas and in tumour development/progression. To test these ideas, we determined the expression of PRC1 complex proteins (Bmi1 and Ring1b) during pancreatic development and in pancreatic tissue from mouse models of disease: acute and chronic pancreatic injury, duct ligation, and in K‐RasG12V conditional knock‐in and caerulein‐treated K‐RasG12V mice. The study was extended to human pancreatic tissue samples. To obtain mechanistic insights, Bmi1 expression in cells undergoing in vitro exocrine cell metaplasia and the effects of Bmi1 depletion in an acinar cancer cell line were studied. We found that Bmi1 and Ring1B are expressed in pancreatic exocrine precursor cells during early development and in ductal and islet cells—but not acinar cells—in the adult pancreas. Bmi1 expression was induced in acinar cells during acute injury, in acinar–ductal metaplastic lesions, as well as in pancreatic intraepithelial neoplasia (PanIN) and PDAC. In contrast, Ring1B expression was only significantly and persistently up‐regulated in high‐grade PanINs and in PDAC. Bmi1 knockdown in cultured acinar tumour cells led to changes in the expression of various digestive enzymes. Our results suggest that Bmi1 and Ring1B are modulated in pancreatic diseases and could contribute differently to tumour development. Copyright © 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Keywords:Polycomb  pancreas  pancreatitis  PDAC  acinoductal metaplasia  immunohistochemistry
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号